Who is sponsoring NCT00180843?

NCT00180843 is sponsored by Imperial College London.

What condition does NCT00180843 study?

NCT00180843 studies Chronic Obstructive Pulmonary Disease.

What drugs are being tested in NCT00180843?

Interventions: salbutamol + ipratropium bromide nebules, nebulized saline.

What is the status of NCT00180843?

NCT00180843 is currently TERMINATED.

Last reviewed 2013-09-21 · How we verify

Assessment of Ventilation-perfusion Abnormalities in Patients With Smoking-related Airways Disease in Stable Condition and the Effect of Bronchodilator Therapy

NCT00180843 NA TERMINATED

Subjects undergo history, examination, lung function assessment after informed consent has been obtained. All subjects will undergo ventilation-perfusion scans. If there first scan is normal they will undergo a second and final scan four weeks later. If abnormal they will undergo two further scans with either nebulized bronchodilator or nebulized saline prior to their second and third scans. Each time they will have repeat lung function tests prior to scanning. We will examine the regional changes in ventilation and perfusion and there relationship to lung function.

Details

Lead sponsor	Imperial College London
Phase	NA
Status	TERMINATED
Enrolment	2
Start date	2005-09
Completion	2008-02

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

salbutamol + ipratropium bromide nebules
nebulized saline

Primary outcomes

scan grade — post scan
previously validated grading score

Countries

United Kingdom